Search
User Profile
Change
Select your user profile
Lp(a): The Science Behind the Risk Factor

Lipoprotein (a), also known as Lp(a), can serve as a clinically useful risk factor for atherosclerotic cardiovascular disease (ASCVD). Lp(a) plays an important role in atherosclerotic and aortic valve disease. Measurement of Lp(a) levels can aid in risk stratification and the triage of patients to more intensive risk factor management. (1)

In November 2023 Roche Diagnostics Australia hosted a complimentary webinar with the aim to educate Australia's healthcare professionals and proactively reduce the one in four (26%) Australian deaths due to cardiovascular disease.  (2) 

Identifying and Managing High Lp(a): Current and Emerging Approaches

"Lp(a) plays an important role in atherosclerotic and aortic valve disease. Measurement of Lp(a) levels currently plays an important role in risk stratification and the triage of patients to more intensive risk factor management"

Prof. Stephen Nicholls

Prof. Nicholls
Identifying and Managing High Lp(a): Current and Emerging Approaches

Lipoprotein (a): What you don't know CAN hurt you?

"...elevated Lp(a) is an independent and causal risk factor for atherosclerotic cardiovascular disease (ASCVD) and calcific aortic valve disease (CAVD)."

A/ Prof. David Sullivan

Prof Sullivan
Lipoprotein(a): What you don’t know Can Hurt You

Lp(a) in Clinical Guidelines and Special Populations

“Lp(a) is the strongest independent risk factor for CVD”

A/Prof. Karam Kostner

Prof Kostner
Lp(a) in Clinical Guidelines and Special Populations

You may also be interested in

...
    ...